Status:
COMPLETED
Odense Androgen Study in the Elderly
Lead Sponsor:
Odense University Hospital
Conditions:
Bone Diseases
Metabolic Syndrome
Eligibility:
MALE
60-75 years
Brief Summary
Introduction Male ageing is associated with sarcopenia, frailty, osteopenia, obesity, the metabolic syndrome and cardiovascular disease. To what extent the androgens affect these signs of ageing is s...
Detailed Description
Introduction Male ageing is associated with sarcopenia, frailty, osteopenia, obesity, the metabolic syndrome and cardiovascular disease. To what extent the androgens affect these signs of ageing is s...
Eligibility Criteria
Inclusion
- Age: 60-75 years
Exclusion
- Cancer
- Severe chronic disease
- Opioid drug addiction
Key Trial Info
Start Date :
March 1 2002
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00155961
Start Date
March 1 2002
Last Update
February 3 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, Odense University Hospital
Odense, Funen, Denmark, 5000